Status of use of protease inhibitors for the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography: An epidemiologic analysis of the evidence-practice gap using a health insurance claims database-Reference-Cited by-同舟云学术

Status of use of protease inhibitors for the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography: An epidemiologic analysis of the evidence-practice gap using a health insurance claims database

Published:2019-06-30 Issue:3 Volume:13 Page:137-144
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Seta Takeshi¹,Takahashi Yoshimitsu²,Yamashita Yukitaka¹,Nakayama Takeo²

Affiliation:

1. Department of Gastroenterology and Hepatology, Japanese Red Cross Society Wakayama Medical Center

2. Department of Health Informatics, Kyoto University School of Public Health

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/13/3/13_2019.01029/_pdf

Reference28 articles.

1. 1. Guyatt G. Evidence-based medicine. ACP J Club (Ann Intern Med). 1991; 114 (suppl 2): A-16.

2. 2. Wada M, Nakayama T, Ishizaki T, Satoh T, Ikeda S. Practice patterns for lower respiratory tract infections in hospital patients with particular focus on bacteriological examinations and injection antibiotics use. Int J Gen Med. 2013; 6:597-604.

3. 3. Kirigaya D, Nakayama T, Ishizaki T, Ikeda S, Satoh T. Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors. Intern Med. 2011; 50:2793-2800.

4. 4. Nakaoka S, Ishizaki T, Urushihara H, Satoh T, Ikeda S, Yamamoto M, Nakayama T. Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010. PLoS One. 2014; 9:e99021.

5. 5. Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims:standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010; 20:413-419.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nafamostat Reduces the Incidence of post‐ERCP Pancreatitis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials;Clinical Pharmacology & Therapeutics;2023-12-29

2. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials;Medicine;2023-10-13

3. Data resource profile: JMDC claims database sourced from health insurance societies;Journal of General and Family Medicine;2021-02-14

4. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Review of Current Preventive Strategies;Clinical and Experimental Gastroenterology;2021-02